Prioritisation of colonoscopy when endoscopy services had resumed
| Prioritisation of endoscopy | Criteria |
| EP1 | Abnormal imaging/rectal mass suspicious of cancer* |
| FIT >60 μgHb/g | |
| Patients >10 week on pathway (excluding polyps and FIT <10 μgHb/g) | |
| EP2 | Any risk and >8 weeks on pathway with no imaging |
| High-risk symptoms with no imaging | |
| High-risk polyps | |
| Non-specific imaging abnormalities | |
| EP3 | High-risk symptoms and normal imaging |
| Standard risk symptoms | |
| FIT 11–59 μgHb/g | |
| Standard risk polyp | |
| EP4 | FIT <10 μgHb/g |
| Low risk polyps | |
| Symptoms not fulfilling NICE guideline NG12 criteria |
*Patients found to have changes consistent with CRC on CT had an expedited LGI endoscopy performed by exception.
CRC, colorectal cancer; EP, endoscopy prioritisation; LGI, lower gastrointestinal; NICE, National Institute for Health and Clinical Excellence.